跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Verbeta 8 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Verbeta 8
Approved
STANDARD
Verbeta 8
Windlas Biotech Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2ae191aa3fa7ef2d
Company
Windlas Biotech Limited
Type
Standard
Approval Details
Approval Id
2ae191aa3fa7ef2d
Drug Approval Philippines Name
Verbeta 8
Product Name
Verbeta 8
Registration Number
DRP-5646-05
Brand Name
Verbeta 8
Generic Name
Betahistine Hydrochloride
Dosage Form
Tablet
Dosage Strength
8 mg
Manufacturer
Windlas Biotech Limited
Importer
Ambica International Trading Corp.
Distributor
Torrent Pharma Philippines, Inc.
Company Detail Path
/organization/windlas-biotech-limited
Issuance Date
02 March 2025
Expiry Date
01 October 2050
Pharmacologic Category
Antivertigo
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2ae191aa3fa7ef2d
Type
Standard
Back to Philippines FDA Approvals